Skip to Content

BCMA-targeted and CAR-T cells therapies for multiple myeloma give a very exciting future and new hope for the patients

In this MEDtalk, Sagar Lonial, Chief Medical Officer, Winship Cancer Institute of Emory University, USA, gives his perspective on the explosion of new BCMA-targeted immune therapies and CAR-T cell therapies with encouraging data. These new treatment targets raise the question of how to sequence treatment. In this MEDtalk, you will get a fresh perspective from one of the leading experts.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top